A patient taking propranolol 20 mg daily continues to have physical symptoms of anxiety (e.g., palpitations, tremor, sweating); what is the appropriate next step in management?

Increase Propranolol Dose or Switch to Alternative Anxiety Treatment

For a patient on propranolol 20 mg daily with persistent physical anxiety symptoms, the appropriate next step is to increase the propranolol dose up to 80-160 mg daily (divided doses or extended-release formulation) or, preferably, switch to a benzodiazepine or SSRI, as propranolol has limited evidence for treating generalized anxiety disorders.

Evidence-Based Rationale

The current evidence does not strongly support propranolol as a first-line treatment for most anxiety disorders. A 2025 systematic review and meta-analysis found no evidence for beneficial effects of beta-blockers compared with placebo or benzodiazepines in patients with social phobia or panic disorder 1. Similarly, a 2016 meta-analysis concluded that the quality of evidence is insufficient to support routine use of propranolol in treatment of anxiety disorders 2.

When Propranolol May Work

Beta-blockers, particularly propranolol, show benefit primarily in:

• Performance anxiety/stage fright - where physical symptoms (tremor, palpitations, sweating) are the primary concern 3, 4
• Anxiety with prominent somatic symptoms related to increased adrenergic tone 5
• Panic disorder with residual cardiovascular symptoms when combined with other agents 6

The guideline literature indicates propranolol is commonly prescribed for symptom relief in panic disorder, combined with cognitive behavioral therapy and/or SSRIs and/or benzodiazepines 3.

Specific Management Algorithm

Step 1: Assess the Type and Severity of Anxiety

• Determine if this is generalized anxiety disorder, panic disorder, social phobia, or performance anxiety
• Identify which physical symptoms predominate: palpitations, tremor, sweating, tachycardia
• Screen for psychiatric comorbidities, especially depression (present in 50% of anxiety patients) 7

Step 2: If Continuing Propranolol

Dose escalation is warranted if the patient has predominantly somatic/cardiovascular symptoms:

• Current dose of 20 mg daily is subtherapeutic for anxiety treatment
• Therapeutic range: 80-320 mg daily for anxiety symptoms 7
• FDA labeling does not include anxiety as an approved indication, but off-label use is common 8
• Start with 80 mg extended-release once daily or 40 mg immediate-release twice daily
• Titrate upward every 3-7 days based on response
• Monitor for bradycardia, hypotension, fatigue, and depression 8

Critical caveat: Even at higher doses, propranolol may only address peripheral manifestations of anxiety without treating the underlying disorder 9, 6.

Step 3: Consider Switching to Evidence-Based Alternatives

Given the lack of robust evidence for propranolol in generalized anxiety 1, 2, strongly consider:

First-line options:

• SSRIs (sertraline, escitalopram, paroxetine) - established efficacy for most anxiety disorders
• Benzodiazepines (lorazepam 0.5-1 mg PO q4-6h PRN) - for acute symptom control 10
  • Note: Risk of dependence with chronic use
  • Best for short-term management while initiating SSRI

Combination approach:

• Add benzodiazepine to propranolol if cardiovascular symptoms persist despite adequate beta-blockade 3, 6
• This may be effective when propranolol alone has failed 9, 5

Step 4: Alternative Beta-Blocker

If preferring to stay with beta-blocker class:

• Atenolol may be better tolerated than propranolol 11
• Preliminary data suggests 100% of patients who switched from propranolol to atenolol preferred atenolol 11
• Atenolol 25-100 mg daily may have fewer CNS side effects (less blood-brain barrier penetration)

Important Contraindications and Monitoring

Before escalating propranolol, exclude:

• Bradycardia (heart rate <60 bpm)
• Hypotension (SBP <90 mmHg)
• Heart block greater than first degree
• Reactive airway disease/asthma 12, 8
• Diabetes - propranolol masks hypoglycemia symptoms 8

Monitor for depression: Beta-blockers can induce or worsen depression, particularly concerning in anxiety patients where depression coexists in 50% of cases 7, 6.

Common Pitfalls to Avoid

1. Underdosing: 20 mg daily is far below the therapeutic range for anxiety (80-320 mg daily) 7
2. Wrong indication: Propranolol works best for performance anxiety and somatic symptoms, not generalized anxiety disorder 5, 1
3. Monotherapy assumption: Most evidence supports propranolol as adjunctive therapy with benzodiazepines or SSRIs, not as sole treatment 3, 6
4. Ignoring depression: Screen for and treat comorbid depression, which may require antidepressants 7
5. Abrupt discontinuation: If switching away from propranolol, taper gradually over several weeks to avoid rebound tachycardia and anxiety 8

Bottom Line

At 20 mg daily, this patient is receiving a subtherapeutic dose for anxiety. However, given the insufficient evidence for propranolol in treating anxiety disorders 1, 2, the most appropriate next step is to transition to an SSRI with or without short-term benzodiazepine support. If the patient specifically has performance anxiety or predominantly cardiovascular symptoms, increase propranolol to 80-160 mg daily. Consider atenolol as an alternative beta-blocker if propranolol side effects are problematic 11.